| Filed On | Filing |
|---|---|
| 27 Oct 2026 |
Form 4: Purkayastha Subrata, Chief Financial Officer
Acquired 35,000 Non-qualified stock options (Option Exercise/Conversion) |
| 27 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
THIS AGREEMENT (this “Agreement”) is made as of the 23rd day of October, 2026 and be effective as November 1, 2026 (the “Effective Date”) by and between Subrata Purkayastha (the “Employee”) and IEH Corporation, a New York corporation (th... |
| 20 Oct 2026 | PROXY STATEMENT |
| 25 Sep 2026 |
8-K: Financial Statements and Exhibits
The orders mark a significant step in IEH's expansion into the medical market, complementing the Company's record defense backlog |
| 08 Sep 2026 |
Form 4/A: Rosenfeld Michael E, Director
Sold 1,200 shares ($39.5K) · Sold 3,800 shares ($124K) |
| 03 Sep 2026 | 144 |
| 02 Sep 2026 | 8-K: Financial Statements and Exhibits |
| 20 Aug 2026 |
Form 4: Rosenfeld Michael E, Director
Sold 3,000 shares ($99K) · Sold 1,240 shares ($40.3K) |
| 17 Aug 2026 |
Form 4: Offerman Gail, 10% owner
Sold 2,000 shares ($64.5K) |
| 07 Aug 2026 | 8-K: Financial Statements and Exhibits |
| 07 Aug 2026 | QUARTERLY REPORT |
| 06 Aug 2026 | 8-K: Other Events |
| 12 Jun 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Jun 2026 | ANNUAL REPORT |
| 08 Jun 2026 | 8-K: Regulation FD Disclosure |
| 18 May 2026 | 8-K: Results of Operations and Financial Condition |
| 22 Apr 2026 | 8-K: Regulation FD Disclosure |
| 26 Mar 2026 | 8-K: Results of Operations and Financial Condition |
| 19 Mar 2026 |
Form 4: Purkayastha Subrata, CFO and Treasurer
Received 15,000 shares by exercise or conversion ($84.8K) · Gave up 4,461 shares to cover exercise price or tax ($84.8K) |
| 19 Mar 2026 |
Form 4: Rosenfeld Michael E, Director
Received 5,000 shares by exercise or conversion ($30.1K) |
Loading...
